0001485003-18-000044.txt : 20180411
0001485003-18-000044.hdr.sgml : 20180411
20180411165843
ACCESSION NUMBER: 0001485003-18-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180409
FILED AS OF DATE: 20180411
DATE AS OF CHANGE: 20180411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HURLY STEPHEN A
CENTRAL INDEX KEY: 0001130637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 18750575
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 FIRST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_152348030962361.xml
FORM 4
X0306
4
2018-04-09
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001130637
HURLY STEPHEN A
C/O ELEVEN BIOTHERAPEUTICS, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
1.5
2018-04-09
4
A
0
250000
0
A
2028-04-08
Common Stock
250000.0
250000
D
On April 9, 2018, the reporting person was awarded options to purchase 250,000 shares of common stock of Eleven Biotherapeutics, Inc. (the "Company"), which options vest 6.25% every three months over four years, provided the reporting person is employed by the Company on each such vesting date.
/s/ Stephen A. Hurly
2018-04-11